Blog

Jun 4, 2019

Marijuana CEO: ‘Many of us are cannabinoid deficient’

Posted by in categories: biotech/medical, health

The growing interest in cannabis and cannabis-derived products has sparked uncertainty and concern over the industry’s lack of regulations. On Thursday, the FDA held a hearing that looked deeper into the science and safety concerns that surround marijuana and CBD.

Medical Marijuana Inc (MJNA) CEO Stuart Titus is optimistic about the effects that cannabis-derived products have on humans.

“We have a very large self-regulatory system in our human bodies called the internal or the endogenous cannabinoid system,” Titus told YFi AM (video above). “And basically since cannabis has been removed from our diets for the past 80-plus years, many of us are cannabinoid deficient, and thus we start taking a nice supplementary-size serving of CBD. Many people are moving to a much higher level of overall health and wellness.”

Read more

Leave a reply